Dr. Lal PathLabs Limited
LALPATHLAB
Rangering i aksjer
#4527
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health... Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
Aksjekurs
$20.26
Sist synkronisert: 2026-10-21
Markedsverdi
$3.39B
Endring (1 dag)
-0.42%
Endring (1 år)
13.73%
Land
IN
Handel Dr. Lal PathLabs Limited (LALPATHLAB)
Kategori
Healthcare
Aksjeprishistorikk for Dr. Lal PathLabs Limited (LALPATHLAB)
Høyeste sluttskurs: $21.17 den 2026-10-01
Laveste sluttskurs: $6.27 den 2015-12-01
Laveste sluttskurs: $6.27 den 2015-12-01
Aksjeprishistorikk for Dr. Lal PathLabs Limited fra 2015 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 9.72% |
| 2025 | -9.00% |
| 2024 | 13.64% |
| 2023 | 8.37% |
| 2022 | -39.10% |
| 2021 | 56.29% |
| 2020 | 40.29% |
| 2019 | 61.30% |
| 2018 | -3.04% |
| 2017 | -13.62% |
| 2016 | 27.11% |
| 2015 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.36 | 50.83% |
CN
|
|
| $177.93 | 21.98% |
US
|
